VanEck Biotech ETF
BBH
BBH
78 hedge funds and large institutions have $85.6M invested in VanEck Biotech ETF in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 33 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
28% less capital invested
Capital invested by funds: $120M → $85.6M (-$33.9M)
39% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 33
Holders
78
Holding in Top 10
–
Calls
$9.51M
Puts
$4.32M
Top Buyers
| 1 | +$1.84M | |
| 2 | +$1.67M | |
| 3 | +$1.09M | |
| 4 |
Millennium Management
New York
|
+$727K |
| 5 |
VF
Virtu Financial
New York
|
+$613K |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$5.08M | |
| 3 | -$3.7M | |
| 4 |
LPL Financial
San Diego,
California
|
-$3.58M |
| 5 |
Goldman Sachs
New York
|
-$3.01M |